Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2020

Jul 17, 2020

SELL
$334.87 - $493.06 $200,922 - $295,836
-600 Closed
0 $0
Q4 2019

Jan 17, 2020

SELL
$319.73 - $374.2 $511,568 - $598,720
-1,600 Reduced 72.73%
600 $222,000
Q1 2019

Apr 18, 2019

SELL
$224.3 - $317.41 $43,065 - $60,942
-192 Reduced 8.03%
2,200 $672,000
Q4 2018

Jan 17, 2019

SELL
$220.1 - $309.0 $1,760 - $2,472
-8 Reduced 0.33%
2,392 $555,000
Q3 2018

Oct 22, 2018

SELL
$289.28 - $326.15 $19,671 - $22,178
-68 Reduced 2.76%
2,400 $751,000
Q1 2018

Apr 30, 2018

SELL
$233.97 - $274.11 $46,794 - $54,822
-200 Reduced 7.5%
2,468 $617,000
Q3 2017

Oct 27, 2017

BUY
$212.27 - $242.28 $566,336 - $646,403
2,668
2,668 $593,000

Others Institutions Holding BIO

About BIO-RAD LABORATORIES, INC.


  • Ticker BIO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 24,633,900
  • Market Cap $8.3B
  • Description
  • Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...
More about BIO
Track This Portfolio

Track Stewart & Patten CO LLC Portfolio

Follow Stewart & Patten CO LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Stewart & Patten CO LLC, based on Form 13F filings with the SEC.

News

Stay updated on Stewart & Patten CO LLC with notifications on news.